Application of Coblation Tonsillectomy with Inferior Pole Capsule Preservation in Pediatric Patients

Jingjia Li1, Lixia Luo2, Weixiong Chen1

  • 1Department of Otolaryngology Head and Neck Surgery, The First People's Hospital of Foshan, Foshan, China.

The Laryngoscope
|September 25, 2020
PubMed

Insights

Coblation tonsillectomy with inferior pole capsule preservation significantly reduces postoperative pain and hemorrhage in children. This technique is safe and effective for treating tonsillar hypertrophy and recurrent tonsillitis.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Minimally Invasive Surgery

Background:

  • Tonsillar hypertrophy and recurrent tonsillitis are common pediatric conditions.
  • Conventional tonsillectomy techniques can be associated with significant postoperative pain and bleeding.
  • Coblation tonsillectomy offers a less invasive approach.

Purpose of the Study:

  • To evaluate the efficacy and benefits of coblation tonsillectomy with inferior pole capsule preservation in pediatric patients.
  • To compare this technique against conventional coblation tonsillectomy regarding postoperative outcomes.

Main Methods:

  • Retrospective chart review of 726 pediatric patients.
  • Patients were divided into two groups: conventional coblation tonsillectomy and coblation tonsillectomy with inferior pole capsule preservation.
  • Comparison of surgical duration, intraoperative bleeding, postoperative pain, and postoperative hemorrhage rates.

Main Results:

  • No significant difference in surgery duration or intraoperative bleeding between groups.
  • Coblation tonsillectomy with inferior pole capsule preservation showed reduced postoperative pain on days 3 and 5.
  • This technique resulted in significantly lower total, secondary, and inferior pole hemorrhage rates.

Conclusions:

  • Coblation tonsillectomy with inferior pole capsule preservation is a safe and effective pediatric surgical option.
  • The technique effectively minimizes postoperative pain and hemorrhage, particularly secondary bleeding.
  • No recurrence of tonsillar hypertrophy or tonsillitis was observed during the 1-year follow-up.
Abstract